• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调控 SIRT2 水平用于人类非小细胞肺癌治疗。

Regulation of SIRT2 levels for human non-small cell lung cancer therapy.

机构信息

Shanghai Lung Cancer Center, Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200030, People's Republic of China.

出版信息

Lung Cancer. 2013 Oct;82(1):9-15. doi: 10.1016/j.lungcan.2013.05.013. Epub 2013 Jul 31.

DOI:10.1016/j.lungcan.2013.05.013
PMID:23915912
Abstract

Seven Sirtuin family members (SIRT1-7), comprising a family of NAD+-dependent protein deacetylases and ADP-ribosyltransferases, are key proteins that regulate multiple physiological processes. SIRT2 was recently reported to play an important role in carcinogenesis. However, its role in non-small cell lung cancer (NSCLC) has not yet been investigated. In this study, we analyzed the expression pattern of SIRT2 in NSCLC tissues from clinical patients and in cell lines, and found that SIRT2 was significantly down-regulated at both the mRNA and protein levels in tumor than non-tumor tissues or cells, which were corroborated by the NSCLC tissue microarray results. Overexpression of SIRT2 in A549 and H1299 cells caused cell proliferation inhibition, cell apoptosis induction and cell cycle arrest. Further analysis showed that SIRT2 overexpression increased the ROS (reactive oxygen species) production and p27 levels. Moreover, up-regulation of SIRT2 in NSCLC cells increased the sensitivity to Cisplatin treatment. Taken together, our results implied that down-regulation of SIRT2 was associated with NSCLC, and regulation of SIRT2 might be an important target for NSCLC therapy.

摘要

七个 Sirtuin 家族成员(SIRT1-7),包括一个 NAD+-依赖性蛋白去乙酰化酶和 ADP-核糖基转移酶家族,是调节多种生理过程的关键蛋白。SIRT2 最近被报道在致癌作用中发挥重要作用。然而,其在非小细胞肺癌(NSCLC)中的作用尚未得到研究。在这项研究中,我们分析了 SIRT2 在临床患者的 NSCLC 组织和细胞系中的表达模式,发现 SIRT2 在肿瘤组织中的 mRNA 和蛋白水平均明显低于非肿瘤组织或细胞,这与 NSCLC 组织微阵列结果相符。SIRT2 在 A549 和 H1299 细胞中的过表达导致细胞增殖抑制、细胞凋亡诱导和细胞周期停滞。进一步分析表明,SIRT2 过表达增加了 ROS(活性氧)的产生和 p27 的水平。此外,在 NSCLC 细胞中上调 SIRT2 增加了对顺铂治疗的敏感性。总之,我们的研究结果表明 SIRT2 的下调与 NSCLC 相关,调节 SIRT2 可能是非小细胞肺癌治疗的一个重要靶点。

相似文献

1
Regulation of SIRT2 levels for human non-small cell lung cancer therapy.调控 SIRT2 水平用于人类非小细胞肺癌治疗。
Lung Cancer. 2013 Oct;82(1):9-15. doi: 10.1016/j.lungcan.2013.05.013. Epub 2013 Jul 31.
2
Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.沉默调节蛋白1和2的表达与非小细胞肺癌患者的不良预后相关。
PLoS One. 2015 Apr 27;10(4):e0124670. doi: 10.1371/journal.pone.0124670. eCollection 2015.
3
SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.SIRT2通过损害Skp2介导的p27降解来抑制非小细胞肺癌细胞的生长。
Oncotarget. 2016 Apr 5;7(14):18927-39. doi: 10.18632/oncotarget.7816.
4
SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A.SIRT2通过靶向JMJD2A抑制非小细胞肺癌的生长。
Biol Chem. 2015 Aug;396(8):929-36. doi: 10.1515/hsz-2014-0284.
5
Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.STAT3 表达的预后意义及其与非小细胞肺癌细胞化疗耐药性的相关性。
Acta Histochem. 2012 Feb;114(2):151-8. doi: 10.1016/j.acthis.2011.04.002. Epub 2011 May 6.
6
SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth.SPOP促进SIRT2降解并抑制非小细胞肺癌细胞生长。
Biochem Biophys Res Commun. 2017 Feb 5;483(2):880-884. doi: 10.1016/j.bbrc.2017.01.027. Epub 2017 Jan 7.
7
Depletion of end-binding protein 1 (EB1) promotes apoptosis of human non-small-cell lung cancer cells via reactive oxygen species and Bax-mediated mitochondrial dysfunction.耗尽末端结合蛋白 1(EB1)通过活性氧和 Bax 介导的线粒体功能障碍促进人非小细胞肺癌细胞凋亡。
Cancer Lett. 2013 Oct 1;339(1):15-24. doi: 10.1016/j.canlet.2013.07.027. Epub 2013 Jul 27.
8
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.MKP1/CL100调控非小细胞肺癌的肿瘤生长及对顺铂的敏感性。
Oncogene. 2006 Jun 1;25(23):3335-45. doi: 10.1038/sj.onc.1209364. Epub 2006 Feb 6.
9
The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.抑癌基因 3p21.3 的 RBM5 可使顺铂耐药的人非小细胞肺癌细胞对顺铂重新敏感。
Cancer Epidemiol. 2012 Oct;36(5):481-9. doi: 10.1016/j.canep.2012.04.004. Epub 2012 May 18.
10
miR-181a and miR-630 regulate cisplatin-induced cancer cell death.miR-181a 和 miR-630 调节顺铂诱导的癌细胞死亡。
Cancer Res. 2010 Mar 1;70(5):1793-803. doi: 10.1158/0008-5472.CAN-09-3112. Epub 2010 Feb 9.

引用本文的文献

1
Sirtuin family in lung adenocarcinoma.肺癌中的沉默调节蛋白家族。
Discov Oncol. 2025 Jul 23;16(1):1398. doi: 10.1007/s12672-025-03217-4.
2
Sirtuin Proteins and Memory: A Promising Target in Alzheimer's Disease Therapy?沉默调节蛋白与记忆:阿尔茨海默病治疗中一个有前景的靶点?
Nutrients. 2024 Nov 27;16(23):4088. doi: 10.3390/nu16234088.
3
Emerging role of sirtuins in non‑small cell lung cancer (Review).沉默信息调节因子 2 相关酶 1 在非小细胞肺癌中的作用(综述)。
Oncol Rep. 2024 Oct;52(4). doi: 10.3892/or.2024.8786. Epub 2024 Aug 2.
4
Casting Light on the Janus-Faced HMG-CoA Reductase Degradation Protein 1: A Comprehensive Review of Its Dualistic Impact on Apoptosis in Various Diseases.揭示两面神 HMG-CoA 还原酶降解蛋白 1 的真面目:其在多种疾病中对细胞凋亡的双重影响的全面综述。
Mol Neurobiol. 2024 Sep;61(9):6842-6863. doi: 10.1007/s12035-024-03994-z. Epub 2024 Feb 14.
5
SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process.SIRT3 激活——药物研发的新希望?深入探讨 SIRT3 生物学及其对药物发现过程的影响
J Med Chem. 2024 Feb 8;67(3):1662-1689. doi: 10.1021/acs.jmedchem.3c01979. Epub 2024 Jan 23.
6
Construction of a prediction model for postoperative prognosis in patients with resectable cholangiocarcinoma based on silence information regulator 2 expression.基于沉默信息调节因子 2 表达构建可切除胆管癌患者术后预后预测模型。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Dec 5;53(1):98-107. doi: 10.3724/zdxbyxb-2023-0413.
7
The sirtuin family in health and disease.长寿蛋白家族与健康和疾病。
Signal Transduct Target Ther. 2022 Dec 29;7(1):402. doi: 10.1038/s41392-022-01257-8.
8
Sirtuins Modulation: A Promising Strategy for HIV-Associated Neurocognitive Impairments.Sirtuins 调节:一种有前途的治疗 HIV 相关神经认知障碍的策略。
Int J Mol Sci. 2022 Jan 7;23(2):643. doi: 10.3390/ijms23020643.
9
The Tubulin Code and Tubulin-Modifying Enzymes in Autophagy and Cancer.自噬与癌症中的微管蛋白密码及微管蛋白修饰酶
Cancers (Basel). 2021 Dec 21;14(1):6. doi: 10.3390/cancers14010006.
10
SNPs in miRNAs and Target Sequences: Role in Cancer and Diabetes.微小RNA及其靶序列中的单核苷酸多态性:在癌症和糖尿病中的作用
Front Genet. 2021 Dec 1;12:793523. doi: 10.3389/fgene.2021.793523. eCollection 2021.